This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates: Archive
Universal Technical Institute (UTI) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Universal Technical (UTI) delivered earnings and revenue surprises of +58.33% and +1.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
UTINegative Net Change ATGENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Mistras (MG) Beats Q2 Earnings Estimates
by Zacks Equity Research
Mistras (MG) delivered earnings and revenue surprises of +11.76% and -0.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MGNo Net Change OSSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of +14.63% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PRCTNegative Net Change NPCENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sunrun (RUN) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Sunrun (RUN) delivered earnings and revenue surprises of +694.44% and +2.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
RUNNegative Net Change CSIQNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sarepta Therapeutics (SRPT) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of +81.98% and +15.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SRPTNegative Net Change BHSTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Steris (STE) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Steris (STE) delivered earnings and revenue surprises of +0.86% and +2.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
STEPositive Net Change SRTSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CareDx (CDNA) delivered earnings and revenue surprises of -16.67% and -4.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CDNANegative Net Change ESTANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Corteva, Inc. (CTVA) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of +16.40% and +3.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CTVANo Net Change ALCOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Immunome, Inc. (IMNM) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Immunome (IMNM) delivered earnings and revenue surprises of +3.85% and +62.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IMNMNegative Net Change DTILNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Keros Therapeutics, Inc. (KROS) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Keros Therapeutics (KROS) delivered earnings and revenue surprises of +33.33% and +135.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KROSPositive Net Change YMABNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Howard Hughes Holdings (HHH) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Howard Hughes Holdings (HHH) delivered earnings and revenue surprises of -56.44% and -12.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HHHPositive Net Change TRUPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Kulicke and Soffa (KLIC) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Kulicke and Soffa (KLIC) delivered earnings and revenue surprises of +16.67% and +2.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KLICNegative Net Change MEINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
PhenixFIN (PFX) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
PhenixFIN (PFX) delivered earnings and revenue surprises of +7.41% and +2.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PFXPositive Net Change WHFPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CF Industries (CF) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CF (CF) delivered earnings and revenue surprises of +0.85% and +9.08%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CFNegative Net Change GPREPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Curaleaf Holdings, Inc. (CURLF) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +14.29% and -0.26%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CURLFNegative Net Change PAHCPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
DHI Group (DHX) Q2 Earnings Surpass Estimates
by Zacks Equity Research
DHI Group (DHX) delivered earnings and revenue surprises of +133.33% and -0.53%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DHXPositive Net Change SMWBNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Warrior Met Coal (HCC) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Warrior Met Coal (HCC) delivered earnings and revenue surprises of +139.29% and +10.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HCCNegative Net Change ACDCPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AerSale Corporation (ASLE) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AerSale (ASLE) delivered earnings and revenue surprises of +300.00% and +29.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ASLEPositive Net Change MRCYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Xencor (XNCR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Xencor (XNCR) delivered earnings and revenue surprises of +47.44% and +116.92%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
XNCRNegative Net Change PSTVNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
electroCore (ECOR) delivered earnings and revenue surprises of -9.38% and +0.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ECORNegative Net Change CATXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Energy Recovery (ERII) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Energy Recovery (ERII) delivered earnings and revenue surprises of +250.00% and +18.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ERIIPositive Net Change DCIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Genco Shipping & Trading (GNK) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Genco Shipping (GNK) delivered earnings and revenue surprises of +6.67% and +2.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GNKNegative Net Change EDRYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Gladstone Commercial (GOOD) Meets Q2 FFO Estimates
by Zacks Equity Research
Gladstone Commercial (GOOD) delivered FFO and revenue surprises of 0.00% and +4.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GOODPositive Net Change LANDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Power Integrations (POWI) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Power Integrations (POWI) delivered earnings and revenue surprises of +2.94% and +0.90%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
POWIPositive Net Change GLOBPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
ARKO Corp. (ARKO) Tops Q2 Earnings Estimates
by Zacks Equity Research
ARKO (ARKO) delivered earnings and revenue surprises of +33.33% and -3.08%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ARKONegative Net Change OLLIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank